{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:49:31Z","timestamp":1781603371157,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023121","name":"Butler Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023121","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xjon.2023.09.031","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T10:20:49Z","timestamp":1696155649000},"page":"656-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Rachel E.","family":"Wittenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Leighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Moleon-Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Borow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald R.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitaram M.","family":"Emani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjon.2023.09.031_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.886208","article-title":"Long-term management of Fontan patients: the importance of a multidisciplinary approach","volume":"10","author":"Martino","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.xjon.2023.09.031_bib2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jtcvs.2007.07.052","article-title":"Critical left ventricular outflow tract obstruction: the disproportionate impact of biventricular repair in borderline cases","volume":"134","author":"Hickey","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2023.09.031_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.pcsu.2021.03.001","article-title":"Left ventricular recruitment in patients with hypoplastic left heart syndrome","volume":"24","author":"Chiu","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"10.1016\/j.xjon.2023.09.031_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.athoracsur.2021.04.058","article-title":"One and one-half ventricle repair: role for restricting antegrade pulmonary blood flow","volume":"114","author":"Prasanna","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2023.09.031_bib5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2012.07.041","article-title":"Staged left ventricular recruitment after single-ventricle palliation in patients with borderline left heart hypoplasia","volume":"60","author":"Emani","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.xjon.2023.09.031_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcp.22081","article-title":"Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations","volume":"223","author":"Psaltis","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.xjon.2023.09.031_bib7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1582-4934.2010.01241.x","article-title":"Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia","volume":"15","author":"See","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.xjon.2023.09.031_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ejhf.829","article-title":"The\u00a0effect of intracoronary infusion of bone marrow-derived mononuclear cells\u00a0on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial","volume":"19","author":"Mathur","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.xjon.2023.09.031_bib9","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehq455","article-title":"Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial","volume":"32","author":"Roncalli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.xjon.2023.09.031_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial\u2020","volume":"37","author":"Choudry","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.xjon.2023.09.031_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-013-0595-9","volume":"102","author":"W\u00f6hrle","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.xjon.2023.09.031_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.116.308639","article-title":"Effect of bone marrow-derived mononuclear cell treatment, early or late after acute myocardial infarction: twelve months CMR and long-term clinical results","volume":"119","author":"S\u00fcrder","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.xjon.2023.09.031_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008460","article-title":"Comparison of mesenchymal stem cell efficacy in ischemic versus nonischemic dilated cardiomyopathy","volume":"7","author":"Tompkins","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.xjon.2023.09.031_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","article-title":"Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure","volume":"81","author":"Perin","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.xjon.2023.09.031_bib15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCRESAHA.116.310253","article-title":"Intracoronary cardiac progenitor cells in single ventricle physiology: the PERSEUS (cardiac progenitor cell infusion to treat univentricular heart disease) randomized phase 2 trial","volume":"120","author":"Ishigami","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.xjon.2023.09.031_bib17","author":"Nelson"},{"key":"10.1016\/j.xjon.2023.09.031_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead002","article-title":"Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial","volume":"3","author":"Kaushal","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.xjon.2023.09.031_bib19","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.113.007412","article-title":"Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices","volume":"129","author":"Ascheim","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.xjon.2023.09.031_bib20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.2019.2341","article-title":"Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial","volume":"321","author":"Yau","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.xjon.2023.09.031_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","article-title":"A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure","volume":"117","author":"Perin","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.xjon.2023.09.031_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCIMAGING.109.928663","article-title":"Validation of 3D echocardiographic assessment of left ventricular volumes, mass, and ejection fraction in neonates and infants with congenital heart disease: a comparison study with cardiac MRI","volume":"3","author":"Friedberg","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.xjon.2023.09.031_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ahj.2017.06.009","article-title":"Study design and rationale for ELPIS: a phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome","volume":"192","author":"Kaushal","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.xjon.2023.09.031_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13238-015-0196-7","article-title":"Direct intercellular communications dominate the interaction between adipose-derived MSCs and myofibroblasts against cardiac fibrosis","volume":"6","author":"Li","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.xjon.2023.09.031_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060161","article-title":"Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts","volume":"8","author":"Kishore","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xjon.2023.09.031_bib26","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.xjon.2023.09.031_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.jvca.2006.02.027","article-title":"Perioperative serum interleukins in neonates with hypoplastic left-heart syndrome and transposition of the great arteries","volume":"21","author":"Appachi","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.xjon.2023.09.031_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy","volume":"69","author":"Hare","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273623003042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666273623003042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:47:59Z","timestamp":1762980479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666273623003042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":27,"alternative-id":["S2666273623003042"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2023.09.031","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2023.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}